Literature DB >> 1575045

Opsonization of middle ear bacteria during chronic suppurative and secretory otitis media.

L E Stenfors1, S Räisänen.   

Abstract

Samples of middle ear effusion were obtained from 16 patients with chronic suppurative otitis media (COM) (20 ears, age range from 1 1/12 to 69 years) and 13 patients with secretory otitis media (SOM) (15 years, age range from 8 months to 13 8/12 years). Qualitative and quantitative bacteriological analyses of the effusions were performed and the intensity of immunoglobulin G (IgG) and complement component C3b adhering to the bacteria was estimated using immunofluorescence technique. In COM effusions, S. aureus in particular was intensely opsonized, whereas Ps. aeruginosa showed minimal, if any, coating with IgG and C3b. SOM effusions exhibited extremely sparse IgG- and C3b-coated bacteria. The difference in IgG and C3b coated bacteria between COM and SOM effusions was significant (p less than 0.01). Specific (IgG) as well as non-specific (C3b) coating of the bacteria that have gained access to the middle ear cavity is of importance for the host defence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575045     DOI: 10.3109/00016489209100789

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Transcriptome signature in young children with acute otitis media due to non-typeable Haemophilus influenzae.

Authors:  Keyi Liu; Linlin Chen; Ravinder Kaur; Michael E Pichichero
Journal:  Int Immunol       Date:  2013-02-14       Impact factor: 4.823

2.  Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.

Authors:  Marisol A Figueira; Sanjay Ram; Richard Goldstein; Derek W Hood; E Richard Moxon; Stephen I Pelton
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

3.  Antibacterial Fusion Proteins Enhance Moraxella catarrhalis Killing.

Authors:  Maisem Laabei; Lucie Colineau; Serena Bettoni; Karolina Maziarz; David Ermert; Kristian Riesbeck; Sanjay Ram; Anna M Blom
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.